Fractyl Health, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Fractyl Health, Inc. (GUTS) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$16.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-08-10
- Fractyl Health, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$25.54M.
- Fractyl Health, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $9.22M.
- Fractyl Health, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$43.73M.
- Fractyl Health, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$45.60M.
- Fractyl Health, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$140.95M.
- Fractyl Health, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$68.69M.
- Fractyl Health, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$77.09M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$25.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$16.32M 10-Q · filed 2026-08-10 | -$60.05M derived: sum of 3 quarters · filed 2026-08-10 | -$105.65M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $9.22M 10-Q · filed 2026-05-12 | -$34.51M derived: sum of 2 quarters · filed 2026-05-12 | -$80.11M derived: sum of 3 quarters · filed 2026-05-12 | -$108.00M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$43.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$89.33M derived: sum of 2 quarters · filed 2026-03-24 | -$117.22M derived: sum of 3 quarters · filed 2026-08-10 | -$140.95M 10-K · filed 2026-03-24 |
| 2025-09-30 | -$45.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$73.49M derived: sum of 2 quarters · filed 2026-08-10 | -$97.23M 10-Q · filed 2025-11-12 | -$122.20M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$27.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$51.62M 10-Q · filed 2026-08-10 | -$76.59M derived: sum of 3 quarters · filed 2026-08-10 | -$99.77M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$23.73M 10-Q · filed 2026-05-12 | -$48.70M derived: sum of 2 quarters · filed 2026-05-12 | -$71.88M derived: sum of 3 quarters · filed 2026-05-12 | -$89.11M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$24.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$48.14M derived: sum of 2 quarters · filed 2026-03-24 | -$65.37M derived: sum of 3 quarters · filed 2026-03-24 | -$68.69M 10-K · filed 2026-03-24 |
| 2024-09-30 | -$23.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$40.40M derived: sum of 2 quarters · filed 2025-11-12 | -$43.72M 10-Q · filed 2025-11-12 | -$62.90M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$17.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$20.55M 10-Q · filed 2025-08-12 | -$39.73M derived: sum of 3 quarters · filed 2025-08-12 | -$55.48M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$3.32M 10-Q · filed 2025-05-13 | -$22.50M derived: sum of 2 quarters · filed 2025-05-13 | -$38.25M derived: sum of 3 quarters · filed 2025-05-13 | -$68.48M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$19.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$34.93M derived: sum of 2 quarters · filed 2025-03-03 | -$65.16M derived: sum of 3 quarters · filed 2025-03-03 | -$77.09M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$15.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$45.98M derived: sum of 2 quarters · filed 2024-11-12 | -$57.91M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$30.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$42.16M 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$11.93M 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |